SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

143 hedge funds and large institutions have $467M invested in Sangamo Therapeutics in 2017 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
+25
Holders Change %
+21.19%
% of All Funds
3.57%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
38
Increased
42
Reduced
34
Closed
13
Calls
$13.2M
Puts
$9.25M
Net Calls
+$3.98M
Net Calls Change
+$2.56M

Top Buyers

1
EC
1
EcoR1 Capital
California
$22.6M
2
Citadel Advisors
2
Citadel Advisors
Florida
$11.8M
3
RCM
3
RA Capital Management
Massachusetts
$11M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$35.2M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$9.83M

Top Sellers

1
Credit Agricole
1
Credit Agricole
France
$0
2
BBA
2
Baker Bros. Advisors
New York
$36.2M
3
GIM
3
Granahan Investment Management
Massachusetts
$6.22M
4
Deutsche Bank
4
Deutsche Bank
Germany
$1.25M
5
CCI
5
Columbus Circle Investors
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
NI
151
Numeric Investors
Massachusetts
– -$99K -19,100 Closed
DTL
152
Dynamic Technology Lab
Singapore
– -$63K -12,177 Closed
Simplex Trading
153
Simplex Trading
Illinois
– -$8K -1,605 Closed
TDC
154
Thompson Davis & Co
Virginia
– -$8K -1,500 Closed
BKA
155
Brick & Kyle Associates
Pennsylvania
– -$6K -1,100 Closed
Fifth Third Bancorp
156
Fifth Third Bancorp
Ohio
– -$2K -400 Closed
3 4 5 6
7